Inflammation and Obesity: The Pharmacological Role of Flavonoids in the Zebrafish Model.
Caterina RussoAlessandro MaugeriLaura MusumeciGiovambattista De SarroSanta CirmiMichele NavarraPublished in: International journal of molecular sciences (2023)
A Mediterranean-style diet is highly encouraged thanks to its healthy food pattern, which includes valuable nutraceuticals such as polyphenols. Among these, flavonoids are associated with relevant biological properties through which they prevent or fight the onset of several human pathologies. Globally, the enhanced incidence of overweight and obese people has caused a dramatic increase in comorbidities, raising the need to provide better therapies. Therefore, the development of sophisticated animal models of metabolic dysregulation has allowed for a deepening of knowledge on this subject. Recent advances in using zebrafish ( Danio rerio ) as model for metabolic disease have yielded fundamental insights into the potential anti-obesity effects of flavonoids. Chronic low-grade inflammation and immune system activation seem to characterize the pathogenesis of obesity; thus, their reduction might improve the lipid profile of obese patients or prevent the development of associated metabolic illnesses. In this review, we highlight the beneficial role of flavonoids on obesity and related diseases linked to their anti-inflammatory properties. In light of the summarized studies, we suggest that anti-inflammatory therapies could have a relevant place in the prevention and treatment of obesity and metabolic disorders.
Keyphrases
- weight loss
- insulin resistance
- metabolic syndrome
- bariatric surgery
- high fat diet induced
- low grade
- type diabetes
- weight gain
- obese patients
- anti inflammatory
- roux en y gastric bypass
- oxidative stress
- gastric bypass
- high grade
- healthcare
- adipose tissue
- skeletal muscle
- risk factors
- risk assessment
- body mass index
- drug induced
- human health
- pluripotent stem cells